Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
Committee decisions: how the House Consumer Protection & Commerce committee voted on March 19, 2025
Loading...
Summary
Summary of chair recommendations and committee actions on bills heard March 19, 2025. Includes final dispositions recorded in the hearing.
The House Committee on Consumer Protection & Commerce completed decision-making on the bills listed below on March 19, 2025. This roundup lists the committee's recorded recommendation, the committee action (pass, pass with amendments, or defer), and any chair-noted appropriations or amendments recorded on the floor.
Votes at a glance (committee-level actions taken March 19, 2025):
- SB137 (electric utilities; cooperative acquisition provisions): Chair recommended and the committee deferred the bill for redrafting to resolve confidentiality, PUC and federal securities concerns (outcome: deferred).
- SB1220 (renewable gas tariff): Committee adopted the chair's recommendation and passed the bill unamended; the PUC will handle procurement and tariff design in a docket (outcome: approved).
- SB1500 (electric utilities; stability measures): Committee passed the bill unamended on the chair's recommendation (outcome: approved).
- SB191 (energy assistance): Committee passed the bill; the chair's report will note a suggested $5,000,000 annual appropriation per year (outcome: approved; committee-noted funding placeholder).
- SB1269 (geothermal resources): Committee passed the bill with amendments; report to note $3,000,000 per year for surface exploration and the chair to add a residential-radius siting restriction (outcome: approved with amendments).
- SB589 (renewable energy; retail wheeling and DER goals): Committee adopted an amendment restricting retail wheeling to state and local government and passed the bill with amendments (outcome: approved with amendments).
- SB1365 (interstate medical licensure compact): Committee passed the bill unamended (outcome: approved).
- SB1429 (medical cannabis): Committee passed the bill with technical amendments: section 3 retroactive to 01/01/2025 (applies only to that section), DOH interim rulemaking and six exempt positions extended to 06/28/2025, and a corrected cross-reference to section 329-122 (outcome: approved with amendments).
- SB1281 (telehealth): Committee passed the bill unamended (outcome: approved).
- SB1509 (prescription drugs; study): Committee deferred the bill to allow parties to refine the study approach (outcome: deferred).
- SB332 (foreclosures): Committee passed the bill with a technical amendment to delete alternate power of sale language and conform the bill text (outcome: approved with amendments).
- SB1100 (biosecurity): Committee passed a substitute position aligning with the House position (HB427 HD2) and added quarantine-authority language and two board members with biosecurity experience (outcome: approved with amendments).
Notes on voting and procedure: the chair repeatedly read the recommendation and recorded members' yea/nay/excused votes on the record for each measure. For measures that passed, the chair's recommendation was adopted by the committee majority; measures identified for deferral were tabled for additional work.
Ending: The committee adjourned following the last vote and directed staff and agencies to follow up on the implementation steps recorded in committee actions.
